Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Well provide you with individualized recommendations from our services
Those in high-risk groups should seek medical advice earlier if symptoms develop
Separate-vial workflow Independent Dose Control - Two Vials, Two Schedules Retatrutide is titrated up in 4-week steps
Track Progress: Celebrate small victories from regular dosing to clothing fitting better
Established thrombotic risk factors commonly present in semaglutide users include: Obesity (BMI 30 kg/m), which increases VTE risk 2-3 fold [13] Type 2 diabetes and insulin resistance Prolonged immobility or sedentary lifestyle History of previous blood clots Active cancer or recent cancer treatment Recent surgery, particularly orthopedic or abdominal procedures Smoking Certain medications, including estrogen-containing contraceptives or hormone replacement therapy Inherited thrombophilias (clotting disorders) Advanced age (risk increases after age 60) Pregnancy and postpartum period (note that semaglutide should be discontinued when pregnancy is recognized) Patients initiating semaglutide should undergo comprehensive baseline assessment including medical history review, with particular attention to prior thrombotic events and family history of clotting disorders
It is estimated that nearly 1.4 billion adults worldwide (over the age of 18, with 20% of women and 25% of men) have hypertension, with a significant portion of cases undiagnosed [1]
